Drug news
FDA approves Betaconnect electronic autoinjector for multiple sclerosis- Bayer HealthCare
The FDA has approved Betaconnect, from Bayer HealthCare, an electronic autoinjector in the treatment of relapsing-remitting multiple sclerosis (RRMS). Betaconnect will be available exclusively to Betaseron (interferon beta-1b) patients beginning in early 2016.
The new autoinjector offers customizable injection speed and depth settings that allow patients to inject quietly with precision at the touch of a button. Additionally, the automatic needle insertion and retraction with a visual and audio end-of-dose indication lets patients know when the injection is complete.